BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6298906)

  • 1. In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I.
    Rivier C; Rivier J; Lederis K; Vale W
    Regul Pept; 1983 Jan; 5(2):139-43. PubMed ID: 6298906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortisol inhibits the ACTH-releasing activity of urotensin I, CRF and sauvagine observed with superfused goldfish pituitary cells.
    Fryer J; Lederis K; Rivier J
    Peptides; 1984; 5(5):925-30. PubMed ID: 6095221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urotensin I, a CRF-like neuropeptide, stimulates acth release from the teleost pituitary.
    Fryer J; Lederis K; Rivier J
    Endocrinology; 1983 Dec; 113(6):2308-10. PubMed ID: 6315348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACTH-releasing activity of urotensin I and ovine CRF: interactions with arginine vasotocin, isotocin and arginine vasopressin.
    Fryer J; Lederis K; Rivier J
    Regul Pept; 1985 May; 11(1):11-5. PubMed ID: 2989979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amunine (ovine CRF), urotensin I and sauvagine, three structurally-related peptides, produce selective dilation of the mesenteric circulation.
    MacCannell KL; Lederis K; Hamilton PL; Rivier J
    Pharmacology; 1982; 25(2):116-20. PubMed ID: 6982480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of corticotropin-releasing factor, arginine vasopressin, and related neuropeptides on the secretion of ACTH and alpha-MSH by frog anterior pituitary cells and neurointermediate lobes in vitro.
    Tonon MC; Cuet P; Lamacz M; Jégou S; Côté J; Gouteaux L; Ling N; Pelletier G; Vaudry H
    Gen Comp Endocrinol; 1986 Mar; 61(3):438-45. PubMed ID: 3007273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the behavioral effects of CRF, sauvagine and urotensin I.
    Britton DR; Hoffman DK; Lederis K; Rivier J
    Brain Res; 1984 Jun; 304(2):201-5. PubMed ID: 6611193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRF, urotensin I, and sauvagine stimulate the release of POMC-derived peptides from goldfish neurointermediate lobe cells.
    Tran TN; Fryer JN; Lederis K; Vaudry H
    Gen Comp Endocrinol; 1990 Jun; 78(3):351-60. PubMed ID: 2161377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the thermogenic effects of CRF, sauvagine and urotensin I in the rat.
    Le Feuvre RA; Rothwell NJ; White A
    Horm Metab Res; 1989 Sep; 21(9):525-6. PubMed ID: 2583676
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin II stimulation of teleost adrenocorticotropic hormone release: interactions with urotensin I and corticotropin-releasing factor.
    Weld MM; Fryer JN
    Gen Comp Endocrinol; 1988 Mar; 69(3):335-40. PubMed ID: 2834258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fish neuropeptide urotensin I: its physiology and pharmacology.
    Lederis K; Fryer JN; Yulis CR
    Peptides; 1985; 6 Suppl 3():353-61. PubMed ID: 3008124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor-like peptides increase cytosolic [Ca2+] in human epidermoid A-431 cells.
    Kiang JG
    Eur J Pharmacol; 1997 Jun; 329(2-3):237-44. PubMed ID: 9226418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the biologic actions of corticotropin-releasing factor and sauvagine.
    Brown MR; Fisher LA; Spiess J; Rivier J; Rivier C; Vale W
    Regul Pept; 1982 Jul; 4(2):107-14. PubMed ID: 6289384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of corticotropin-releasing factor-stimulated adenylate cyclase activity in rat retina.
    Olianas MC; Onali P
    J Neurochem; 1990 Jun; 54(6):1967-71. PubMed ID: 2159980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sauvagine induces release of adrenocorticotropin, beta-endorphin and corticosterone in rats.
    Negri L; Melchiorri P; Montecucchi PC; Henschen A; D'Urso R; Iellamo R; Falaschi P
    Pharmacol Res Commun; 1983 Apr; 15(4):427-38. PubMed ID: 6306700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocorticotropic hormone-releasing activity of urotensin I and its fragments in vitro.
    Ohta N; Mochizuki T; Hoshino M; Jun L; Kobayashi H; Yanaihara N
    J Pept Res; 1997 Sep; 50(3):178-83. PubMed ID: 9309581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro comparisons of biological activities of bovine, ovine and rat CRF (corticotrophin-releasing factor).
    Yasuda N; Yasuda Y; Aizawa T; Maruta S; Greer MA
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):158-67. PubMed ID: 6328821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of CRF- and urotensin I-stimulated ACTH release from goldfish pituitary cell columns by the CRF analogue alpha-helical CRF-(9-41).
    Weld MM; Fryer JN; Rivier J; Lederis K
    Regul Pept; 1987 Dec; 19(5-6):273-80. PubMed ID: 2830643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells.
    Heldwein KA; Redick DL; Rittenberg MB; Claycomb WC; Stenzel-Poore MP
    Endocrinology; 1996 Sep; 137(9):3631-9. PubMed ID: 8756527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
    Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
    Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.